主要著作及论文 著作:2016,上海科学技术出版社《药物化学》(第2版),编委 论文:(1) Ling Yu; Zhiwei Yan; Youde Wang; Hao Miao; Jingyi Zhao; Chong Pang; Shuai Li ; Recent advances in structural types and medicinal chemistry of PARP-1 inhibitors, Medicinal Chemistry Research, 2022, 31: 1265-1276 (2) Shuai Li; Xinyang Li; Tingjian Zhang; Ju Zhu; Kaili Liu; Depu Wang; Fanhao Meng ; Novel 4,5-dihydrospiro[benzo[c]azepine-1,1 '-cyclohexan]-3(2H)-one derivatives as PARP-1 inhibitors: Design, synthesis and biological evaluation, Bioorganic Chemistry, 2021, 111: 104840 (3) Shuai Li; Xinyang Li; Tingjian Zhang; Ju Zhu; Wenhan Xue; Xinhua Qian; Fanhao Meng ; Design, synthesis and biological evaluation of erythrina derivatives bearing a 1,2,3-triazole moiety as PARP-1 inhibitors, Bioorganic Chemistry, 2020, 96: 103575 (4) Shuai Li; Xinyang Li; Tingjian Zhang; Mohamed Olounfeh Kamara; Jingwei Liang; Ju Zhu; Fanhao Meng ; Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs, Bioorganic Chemistry, 2020, 94: 103385 (5) Xinyang Li; Shuai Li; Guoqing Lu; Depu Wang; Kaili Liu; Xinhua Qian; Wenhan Xue; Fanhao Meng ; Design, synthesis and biological evaluation of novel (E)-N-phenyl-4-(pyridineacylhydrazone) benzamide derivatives as potential antitumor agents for the treatment of multiple myeloma (MM), Bioorganic Chemistry, 2020, 103: 104189(共同一作) (6) Yatao Huang; Shuai Li; Youde Wang; Zhiwei Yan; Yachun Guo and Liying Zhang; A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Potential Therapeutic Effect on Cerebral Ischemia, Molecules, 2022, 27, 6333(共同一作) |
承担课题情况 (1) 国家自然科学基金青年科学基金项目, 82204210, 基于天然来源生物碱的新型PARP-1/FTase双靶点抑制剂的设计、合成及抗KRAS突变肺癌的机制研究, 2023-01-01 至 2025-12-31, 30万元, 主持 (2) 河北省自然科学基金联合基金-生物医药联合基金培育项目, H2022406062, 基于高刺桐生物碱的新型PARP-1/EZH2双靶点抑制剂的设计、合成及抗BRCA野生型肺癌的机制研究, 2022-01 至2025-12, 10万元, 主持 (3) 河北省高等学校科学技术研究青年基金项目, QN2022161, 新型苯并螺环类PARP-1抑制剂的设计、合成及生物活性研究, 2022-01 至 2024-12, 3万元, 主持 (4) 承德医学院高层次人才科研启动基金项目,202207,型PARP-1抑制剂的设计合成及活性评价,2022-01至2024-12,25万元,主持 |